Expert Review of Hematology, Volume 10, Issue 5 (2017)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Hematology, Volume 10, Issue 5 (2017)

See all volumes and issues
Vol 17, 2024 Vol 16, 2023 Vol 15, 2022 Vol 14, 2021 Vol 13, 2020 Vol 12, 2019 Vol 11, 2018 Volume 10, 2017 Vol 9, 2016 Vol 8, 2015 Vol 7, 2014 Vol 6, 2013 Vol 5, 2012 Vol 4, 2011 Vol 3, 2010 Vol 2, 2009 Vol 1, 2008
Download citations Download PDFs Download issue

Special Report

Article
Super-resolution microscopy in the diagnosis of platelet granule disorders
Alex E. Knight, Keith Gomez & Daniel F. Cutler
Pages: 375-381
Published online: 13 Apr 2017
AbstractforSuper-resolution microscopy in the diagnosis of platelet granule disorders | Full Text | References | PDF (1.2 MB)
  • 2219 Views
  • 7 CrossRef citations
  • 0Altmetric
Open Access

Perspective

Article
Which therapies will move to the front line for multiple myeloma?
María J Cejalvo & Javier de la Rubia
Pages: 383-392
Published online: 24 Apr 2017
AbstractforWhich therapies will move to the front line for multiple myeloma? | Full Text | References | PDF (779.6 KB)
  • 518 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Minimal residual disease or cure in MPNs? Rationales and perspectives on combination therapy with interferon-alpha2 and ruxolitinib
Mads Emil Bjørn & Hans Carl Hasselbalch
Pages: 393-404
Published online: 12 Apr 2017
AbstractforMinimal residual disease or cure in MPNs? Rationales and perspectives on combination therapy with interferon-alpha2 and ruxolitinib | Full Text | References | PDF (955.2 KB)
  • 641 Views
  • 24 CrossRef citations
  • 0Altmetric

Review

Review
Lymphoma classification update: B-cell non-Hodgkin lymphomas
Manli Jiang, N. Nora Bennani & Andrew L. Feldman
Pages: 405-415
Published online: 24 Apr 2017
AbstractforLymphoma classification update: B-cell non-Hodgkin lymphomas | Full Text | References | PDF (1.4 MB)
  • 2383 Views
  • 40 CrossRef citations
  • 0Altmetric
Review
Immunotherapy for the treatment of Hodgkin lymphoma
Eva M. Donato, Miguel Fernández-Zarzoso & Javier De La Rubia
Pages: 417-423
Published online: 12 Apr 2017
AbstractforImmunotherapy for the treatment of Hodgkin lymphoma | Full Text | References | PDF (583.6 KB)
  • 524 Views
  • 12 CrossRef citations
  • 0Altmetric
Review
Targeted therapy in the treatment of chronic lymphocytic leukemia: facts, shortcomings and hopes for the future
Stefano Molica
Pages: 425-432
Published online: 12 Apr 2017
AbstractforTargeted therapy in the treatment of chronic lymphocytic leukemia: facts, shortcomings and hopes for the future | Full Text | References | PDF (650.2 KB)
  • 341 Views
  • 4 CrossRef citations
  • 0Altmetric
Review
Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review
Prajwal Chaitanya Boddu & Tapan Mahendra Kadia
Pages: 433-448
Published online: 28 Apr 2017
AbstractforUpdates on the pathophysiology and treatment of aplastic anemia: a comprehensive review | Full Text | References | PDF (1.3 MB)
  • 1344 Views
  • 25 CrossRef citations
  • 0Altmetric
Review
Should modulation of p50 be a therapeutic target in the critically ill?
Amudan J. Srinivasan, Clare Morkane, Daniel S. Martin & Ian J. Welsby
Pages: 449-458
Published online: 12 Apr 2017
AbstractforShould modulation of p50 be a therapeutic target in the critically ill? | Full Text | References | PDF (988.7 KB)
  • 458 Views
  • 23 CrossRef citations
  • 0Altmetric
Review
Management of myelofibrosis: JAK inhibition and beyond
Maximilian Stahl & Amer M. Zeidan
Pages: 459-477
Published online: 26 Apr 2017
AbstractforManagement of myelofibrosis: JAK inhibition and beyond | Full Text | References | PDF (1.5 MB)
  • 685 Views
  • 10 CrossRef citations
  • 0Altmetric
Review
Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?
Alberto Mussetti, Raffaella Greco, Jacopo Peccatori & Paolo Corradini
Pages: 479-492
Published online: 05 May 2017
AbstractforPost-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand? | Full Text | References | PDF (1.1 MB)
  • 809 Views
  • 32 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

T-cell exhaustion in multiple myeloma
Krzysztof Żyłka et al.
Review Article | Published online: 26 Jun 2024
Sickle cell disease and infertility risks: implications for counseling and care of affected girls and women
Lydia H. Pecker et al.
Review Article | Published online: 26 Jun 2024
Is 50 mg/day the new standard dose of dasatinib in newly diagnosed patients with chronic myeloid leukemia in chronic phase?
Betül Saydan et al.
Editorial | Published online: 25 Jun 2024
Free Access
Screening and interventional strategies for the late effects and toxicities of hematological malignancy treatments in pediatric survivors
Kazuo Sakashita et al.
Review Article | Published online: 25 Jun 2024
View all latest articles